BIO (BioProtocol) fluctuates 42.0% within 24 hours, trading volume surges by $139 million driving a 23.1% rebound
Bitget Pulse2026/04/28 21:00Volatility Overview
In the past 24 hours, the price of BIO rebounded from a low of $0.02766 to a high of $0.03928 (CoinGecko data shows a high of $0.03571 and a low of $0.02775). The current price is $0.03609, representing an overall increase of 23.1% and a swing of up to 42.0%. Trading volume soared to $139 million, with a market capitalization of approximately $75.49 million. Upbit (BIO/KRW) and Binance (BIO/USDT) accounted for over 37% of the transactions.
Brief Analysis of the Causes of the Movement
- No official announcements, major news, or on-chain anomalies (such as large whale transfers) were observed in the past 24 hours.
- Trading volume increased significantly ($139 million), with Korea's Upbit exchange leading with 19.81% of trades, and the Binance USDT/TRY pair accounting for 23.68%. This indicates active buying drove the rebound.
Market View and Outlook
Market sentiment is moderately cautious, with few related discussions on X within 24 hours. Some traders previously noted resistance after the pump (such as rejection near $0.040), focusing on the $0.032–$0.030 support zone, with short-term high volatility risk highlighted. CMC data shows a 5.49% increase on the 27th and a decline of 10.15% during some periods on the 28th due to the broader market influence.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Apple Pre-sale Tracker: iPhone 18 Pro Series Shows Weak Overseas Demand Signals, Duo Review Positive but Hardware Lags Behind
According to a survey by Jefferies, after the launch of the iPhone 18 Pro, delivery wait times in the four major markets—the US, UK, Germany, and Japan—have shortened by 5 to 11 days compared to last year, with no wait time in the US. Given stable production capacity, this is a clear sign of weak demand. Although the China and Hong Kong markets have performed better against the trend, there are still suspicions of speculative stockpiling. The new foldable Duo has been praised for its software experience, but its $2,000 price tag comes with a 254-gram body and dual-camera setup, leaving its hardware lagging significantly behind Android competitors. Jefferies maintains an "underperform" rating, with a target price implying a 21% downside from the current level.
UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs
In the annual survey by UBS for employee benefits management institutions, Elevance Health (ELV.US) emerged as the highest-rated US health insurance company.

LINK Targets $11.50 as LINK/BTC Approaches a Critical Breakout Zone

Solana breaks resistance, holds above $100 as analysts target $147